Mölnlycke Health Care
Mölnlycke Health care wins patent infringement case regarding its Mepilex Border products in Germany
Smith & Nephew must immediately remove all Allevyn Gentle Border products from the German supply chain and market.
Mölnlycke Health Care announces that on 16 March 2010, the District Court in Dusseldorf, Germany ruled that all of Smith & Nephew’s Allevyn Gentle Border products infringe Mölnlycke’s EU patent EP0 633 757, which protects Mölnlycke’s Mepilex Border products.
Smith & Nephew has appealed the decision, but the Court has provisionally permitted Mölnlycke to enforce the decision. Accordingly, Smith & Nephew must remove from the entire German supply chain and market all offending products, by way of recall. Customers should expect to be contacted by Smith & Nephew for the return of product.
Mölnlycke remains confident in the strength of its patent and will assist customers in the transition out of infringing products.
For further information please contact:
Robert M. Bennison
Senior Vice President for Legal, Regulatory and Quality Affairs